BioCorRx (BICX) Common Equity (2010 - 2026)
BioCorRx (BICX) posted Common Equity of -$180813.0 for Q1 2026, up 98.43% sequentially from -$11.5 million in Q4 2025, and up 98.47% YoY from -$91104.4 in Q1 2025.
BioCorRx (BICX) Common Equity (2010 - 2026) Analysis & Trends
BioCorRx has reported Common Equity for 17 years, with the latest figure at -$180813.0 in Q1 2026.
- Quarterly Common Equity rose 98.47% year-over-year to -$180813.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$180813.0 (up 98.47% YoY) and the FY2025 annual result came in at -$11.5 million, up 6.7% from the prior year.
- Common Equity improved to -$180813.0 in Q1 2026 per BICX's latest filing, from -$11.5 million in the prior quarter.
- Over five years, Common Equity peaked at $5616.0 in Q3 2025 and troughed at -$12.4 million in Q4 2024.
- A 5-year average of -$8.5 million and a median of -$9.0 million in 2023 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2025: Common Equity tumbled 93.72% in 2022, then surged 100.05% in 2025.
- Over 5 years, Common Equity stood at -$8.2 million in 2022, then dropped by 21.35% to -$10.0 million in 2023, then slipped by 24.14% to -$12.4 million in 2024, then increased by 6.7% to -$11.5 million in 2025, then surged by 98.43% to -$180813.0 in 2026.
- According to Business Quant data, Common Equity over the past three periods registered -$180813.0, -$11.5 million, and $5616.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | -6.64 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 6.56 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 3.40 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | -765.10 Mn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 2.45 Bn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 7.58 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 1.12 Bn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 830.51 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 484.72 Mn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -180,813.00 |
| Dec 31, 2025 | -11.53 Mn |
| Sep 30, 2025 | 5,616.00 |
| Mar 31, 2025 | -11.80 Mn |
| Dec 31, 2024 | -12.36 Mn |
| Sep 30, 2024 | -12.00 Mn |
| Jun 30, 2024 | -11.15 Mn |
| Mar 31, 2024 | -10.87 Mn |
| Dec 31, 2023 | -9.95 Mn |
| Sep 30, 2023 | -9.26 Mn |
| Jun 30, 2023 | -8.71 Mn |
| Mar 31, 2023 | -8.83 Mn |
| Dec 31, 2022 | -8.20 Mn |
| Sep 30, 2022 | -7.20 Mn |
| Jun 30, 2022 | -7.46 Mn |
| Mar 31, 2022 | -6.75 Mn |
| Dec 31, 2021 | -6.96 Mn |
| Sep 30, 2021 | -5.80 Mn |
| Jun 30, 2021 | -4.49 Mn |
| Mar 31, 2021 | -3.49 Mn |